oxyglobin
opk biotech netherlands bv - hemoglobiini glutameeri-200 (naudat) - veren korvikkeet ja perfuusioliuokset - koirat - oxyglobin tarjoaa happea kantavaa tukea koirille, jotka parantavat anemian kliinisiä oireita vähintään 24 tunnin ajan, riippumatta taustalla olevasta tilasta.
revolade
novartis europharm limited - eltrombopag - purpura, trombosytopeeninen, idiopaattinen - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 ja 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 ja 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.
pixuvri
les laboratoires servier - pixantrone dimaleaatti - lymfooma, ei-hodgkin - antineoplastiset aineet - pixuvri on merkitty monoterapiana sellaisten aikuispotilaiden hoidossa, joilla on moninkertainen relapsoitu tai tulenkestävä aggressiivinen ei-hodgkin b-solulymfooma (nhl). pixantrone-hoidon etua ei ole osoitettu potilaille, kun sitä käytetään viidennen tai useamman solunsalpaajahoitona potilaille, jotka ovat tulenkestäviä viimeisestä hoidosta.
covid-19 vaccine (inactivated, adjuvanted) valneva
valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - rokotteet - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age. the use of this vaccine should be in accordance with official recommendations.
pepaxti
oncopeptides ab - melphalan flufenamide hydrochloride - multiple myeloma - antineoplastiset aineet - pepaxti is indicated, in combination with dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least three prior lines of therapies, whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one anti-cd38 monoclonal antibody, and who have demonstrated disease progression on or after the last therapy. for patients with a prior autologous stem cell transplantation, the time to progression should be at least 3 years from transplantation (see section 4.
nespo
dompé biotec s.p.a. - darbepoetiini alfa - kidney failure, chronic; anemia; cancer - antianemiset valmisteet - krooniseen munuaisten vajaatoimintaan (crf) liittyvän oireisen anemian hoito aikuisilla ja pediatrisilla potilailla. oireisen anemian hoito solunsalpaajia saavilla aikuisilla syöpäpotilailla, joilla on ei-myeloidinen syöpä.
selukos 25 mg/g shampoo
meda oy - selenii sulfidum - shampoo - 25 mg/g - seleeniyhdisteet
breakyl 200 mikrog bukkaalikalvo
meda oy - fentanyli citras - bukkaalikalvo - 200 mikrog - fentanyyli
breakyl 400 mikrog bukkaalikalvo
meda oy - fentanyli citras - bukkaalikalvo - 400 mikrog - fentanyyli
breakyl 600 mikrog bukkaalikalvo
meda oy - fentanyli citras - bukkaalikalvo - 600 mikrog - fentanyyli